FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 68 filers reported holding FULCRUM THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,391,832 | +34.5% | 5,718,881 | 0.0% | 1.37% | +36.0% |
| Q2 2023 | $18,872,307 | +27.9% | 5,718,881 | +10.5% | 1.01% | +62.0% |
| Q1 2023 | $14,756,474 | -52.6% | 5,177,710 | +21.1% | 0.62% | -52.3% |
| Q4 2022 | $31,120,566 | +9.0% | 4,274,803 | +21.2% | 1.31% | +10.3% |
| Q3 2022 | $28,542,000 | +73.6% | 3,528,000 | +5.1% | 1.18% | +89.6% |
| Q2 2022 | $16,443,000 | -73.4% | 3,355,624 | +28.4% | 0.62% | -66.9% |
| Q1 2022 | $61,807,000 | +47.1% | 2,613,412 | +10.0% | 1.89% | +131.9% |
| Q4 2021 | $42,024,000 | -23.3% | 2,375,571 | +22.3% | 0.81% | -11.8% |
| Q3 2021 | $54,783,000 | +221.2% | 1,941,969 | +19.3% | 0.92% | +262.0% |
| Q2 2021 | $17,056,000 | -5.1% | 1,627,444 | +6.7% | 0.26% | -4.1% |
| Q1 2021 | $17,975,000 | – | 1,525,885 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,962,202 | $19,415,000 | 7.94% |
| TRV GP IV, LLC | 2,343,154 | $11,481,000 | 7.55% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 949 | $193,741,000 | 2.02% |
| Logos Global Management LP | 1,950,000 | $9,555,000 | 1.75% |
| COWEN AND COMPANY, LLC | 2,385,885 | $11,691,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,355,624 | $16,443,000 | 0.62% |
| ACUTA CAPITAL PARTNERS, LLC | 200,000 | $980,000 | 0.55% |
| RTW INVESTMENTS, LP | 3,961,194 | $19,410,000 | 0.50% |
| Parkman Healthcare Partners LLC | 262,689 | $1,287,000 | 0.47% |
| Deep Track Capital, LP | 1,000,000 | $4,900,000 | 0.32% |